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Abstract
Vascular endothelial growth factor (VEGF) signal transduction is central to angiogenesis in development and in
pathological conditions such as cancer, retinopathy and ischemic diseases. However, no detailed mass-action
models of VEGF receptor signaling have been developed. We constructed and validated the first computational
model of VEGFR2 trafficking and signaling, to study the opposing roles of Gab1 and Gab2 in regulation of Akt
phosphorylation in VEGF-stimulated endothelial cells. Trafficking parameters were optimized against 5 previously
published in vitro experiments, and the model was validated against six independent published datasets. The model
showed agreement at several key nodes, involving scaffolding proteins Gab1, Gab2 and their complexes with Shp2.
VEGFR2 recruitment of Gab1 is greater in magnitude, slower, and more sustained than that of Gab2. As Gab2 binds
VEGFR2 complexes more transiently than Gab1, VEGFR2 complexes can recycle and continue to participate in
other signaling pathways. Correspondingly, the simulation results show a log-linear relationship between a decrease
in Akt phosphorylation and Gab1 knockdown while a linear relationship was observed between an increase in Akt
phosphorylation and Gab2 knockdown. Global sensitivity analysis demonstrated the importance of initial-
concentration ratios of antagonistic molecular species (Gab1/Gab2 and PI3K/Shp2) in determining Akt
phosphorylation profiles. It also showed that kinetic parameters responsible for transient Gab2 binding affect the
system at specific nodes. This model can be expanded to study multiple signaling contexts and receptor crosstalk
and can form a basis for investigation of therapeutic approaches, such as tyrosine kinase inhibitors (TKIs),
overexpression of key signaling proteins or knockdown experiments.
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Introduction
Vascular Endothelial Growth Factor (VEGF) signal
transduction in angiogenesis is a biologically significant
process both for physiological development and for
pathological conditions such as cancer, ocular diseases [1–3]
and ischemic diseases [4]. In particular, approved anti-
angiogenic drugs have shown promise in the treatment of
cancer and age-related macular degeneration. These drugs
include anti-VEGF monoclonal antibodies (eg. bevacizumab,
ranibizumab), tyrosine kinase inhibitors (eg. sorafenib,
sunitinib) and anti-VEGF aptamers (eg. pegaptanib) [5]. Many
more such drugs are in clinical trials and pre-clinical
development. While the putative drug targets and primary
mechanisms of action are sometimes known, secondary
targets and side-effects of these drugs are difficult to predict.
Furthermore, drug efficacy is highly variable, patient-specific,
and largely associated with innate and acquired resistance of
multiple cancer cell types [1]. VEGF acts by binding to and
activating receptor tyrosine kinases (VEGFRs) on cell surfaces.
The multiple signaling pathways downstream of VEGF
activation of VEGFRs are dynamic and heavily coupled; cross-
talk interactions between them influence cell phenotypes.
Computational models have the potential to describe, explain
and predict VEGF signal transduction under various conditions,
including quiescence, disease and drug interventions.
The VEGF-VEGFR system is complex. In humans, it
consists of five ligands (VEGF-A through -D and PlGF,
placental growth factor) each with multiple isoforms, three
receptor tyrosine kinases (VEGFR1, VEGFR2, VEGFR3),
which actively signal as homo- and heterodimers in various
combinations, and two nonsignaling co-receptors (NRP-1 and
NRP-2). Here we present a mass-action ordinary differential
equation (ODE) model describing VEGF-A (herein referred to
as VEGF) stimulation of VEGFR2 homodimers in vitro because
this receptor-ligand pair is primarily accountable for activating
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main signaling cascades in endothelial cells (eg. PI3K/Akt
pathway). These pathways then lead to the activation of
physiologically significant cellular processes including
migration, adhesion, angiogenesis, vascular permeability, and
vasodilation.
Mass action models of receptor tyrosine kinase (RTK)
signaling have been developed for the ErbB or EGFR
(epidermal growth factor receptor) family [6–11], and for
platelet-derived growth factor receptors, PDGFRs [12–15] but
less so for VEGFRs [16,17]. The above-mentioned receptors
are structurally similar and their downstream effectors are
similar in many ways (eg. PI3K/Akt pathway, MAPK cascade),
though they often appear in different cell types. However, the
biological outcomes of these signal transduction pathways may
differ between cell types. Often, EGFRs in epithelial cells are
associated with regulation of proliferation, PDGFRs in
fibroblasts with wound healing and VEGFRs in endothelial cells
with angiogenesis.
To initiate signaling, the bivalent VEGF ligand binds two
VEGFR monomers. There are two possible mechanisms:
ligand-induced dimerization or ligand binding to pre-dimerized
receptors [18]. Upon ligation, the cytoplasmic tails of VEGFR2s
autophosphorylate on residues Y1175, Y1214, and other
tyrosine sites [19]. These phosphotyrosine sites then recruit
adaptor molecules such as Shc and Grb2. Adaptor molecules
lack enzymatic function and instead act as molecular bridges
between multiple proteins. Scaffolding or docking proteins bind
to adaptor proteins, joining the receptor complex. Scaffolding
proteins consist of multiple binding domains and hence are
generally larger than adaptor proteins [20]. Adaptor and
scaffolding proteins generally contain Src homology-2 (SH2)
domains that are responsible for their recruitment to the
receptor at the phosphotyrosine sites [21]. These then lead to
the activation of highly conserved signaling pathways such as
MAPK cascade, PI3K/Akt pathway and PLCγ/PKC pathway.
These pathways activate a diverse set of cellular responses
e.g. proliferation, migration, apoptosis.
Differences in signal transduction between the various
receptor-ligand systems can be attributed to scaffolding
proteins proximal to the receptors, which are system-specific.
This may then lead to differential activation of downstream
pathways. In vitro experimental evidence suggests that Grb2-
associated binder (Gab) proteins have different downstream
effects in different receptor-ligand systems. In VEGF-stimulated
human microvascular endothelial cells (HMVECs), siRNA
experiments show that Gab1 positively regulates Akt activation,
while Gab2 has the opposite effect [22,23]. In addition, Gab2
only transiently binds the receptor while Gab1 association with
the receptor occurs over longer time scales [22]. In contrast, in
the EGF-EGFR system, Gab1 and Gab2 positively regulate Akt
activation, though interestingly the more transient binding of
Gab2 relative to Gab1 is again observed [24]. 14-3-3 proteins
have been shown to be responsible for mediating Gab2
dissociation from the receptor complex [25]. In the Heregulin
(HRG)-Erb2/3 system, it is suggested that Gab2 negatively
regulates Akt phosphorylation through negative feedback,
where the dissociation of Gab2 from the receptor is mediated
by Akt [26]. These three examples illustrate that Gab2 may act
through distinctly different mechanisms, depending on the
receptor-ligand pair. The transient nature of Gab2-receptor
association renders it more difficult to study in situ. Hence,
there is a motivation to model the kinetics of scaffolding
proteins in silico.
Although Gab2-knockout mice are not embryonic lethal like
Gab1-knockout mice are, Gab2-mediated signaling does have
a functional role [20]. Gab2 has been found to be amplified and
overexpressed in human breast cancer cell lines as well as in
primary tumors, and was proposed to be involved in mammary
carcinogenesis [27]. Gab2 has also been found to be amplified
and overexpressed in melanoma, more so in metastatic than
primary melanoma [28]. The relevance of Gab proteins in cell
homeostasis and disease progression motivates the inclusion
of both Gab1 and Gab2 proteins in signal transduction models.
The purpose of this study is to evaluate the highly transient
nature of Gab2 action, which is difficult to study in vitro, but has
significant effects on Akt phosphorylation downstream in the
context of VEGF-stimulated endothelial cells [22]. The negative
regulation of Akt through the dissociation of Gab2 from RTKs
has been experimentally validated in the HRG-ErbB2-ErbB3
system [26] and serves as a guide to the mechanisms modeled
in this study. We hypothesized that Shp2 is responsible for
mediating Gab2 dissociation from the VEGFR2 receptor
complex (Figure 1). This dissociation reaction results in Gab2
sequestration of PI3K, preventing further activation of Akt. As a
non-receptor protein tyrosine phosphatase, Src homology-2
domain-containing phosphatase (Shp2) does not act directly to
dephosphorylate VEGFR. Rather, the Shp2 binding blocks
Gab1 recruitment of the p85 subunit of PI3K, and promotes
signaling through the ERK pathway instead [20]. Gab2 and
Shp2 interactions have been implicated in BCR/ABL
transformation [29] and breast carcinogenesis [27,30].
Shp2 regulates PI3K activation differently in the Epidermal
Growth Factor Receptor (EGFR), Platelet-Derived Growth
Factor Receptor (PDGFR) and Insulin-like Growth Factor
Receptor (IGFR) systems [31]. Such differences are a common
theme in the reactions of scaffolding proteins, which have
multiple binding domains and can potentially form complexes
with combinations of other scaffolding proteins. Systems
biology is a useful tool to understand these reactions initiated
by ligand stimulation, which may be difficult to detect or
analyze in situ. Importantly, systems biology provides an
opportunity to understand which of these interactions are
significant, in the context of other signaling pathways that may
be activated in parallel. Such analyses may allow the
identification of novel therapeutic targets. The molecular
species to which the system is most sensitive may also be
useful as biomarkers in guiding experimental studies and
eventually in the clinical setting.
Methods
Formulation of biochemical reactions
To simulate in vitro cell culture experiments in which primary
endothelial cells are stimulated with exogenously added VEGF,
we developed a deterministic mass-action ODE model. In our
model, aside from VEGF binding to VEGFR2, all pertinent
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reactions take place inside the cell, with 71 reactions involving
14 distinct proteins and 43 kinetic parameters. The interior of
the cell is divided into three compartments, and molecules can
move between them: the cell surface compartment; the
internalized compartment (representing early endosomes); and
the degraded compartment (representing irreversible entry into
late endosomes/lysosomes). The list of reactions (Table S1,
with initial conditions in Table S2 and kinetic parameters in
Table S3, all in File S1) is based on the reaction network in
Figure 1 and Figure S1 in File S1, and is compiled into a model
using the MATLAB Simbiology toolbox. The system is solved
using ode15s, one of MATLAB’s stiff ODE solvers. Here, our
primary interest is in early signaling events, and the simulations
produce concentration profiles of intracellular signaling
Figure 1.  Reaction Schematic.  A, The scaffolding proteins Gab1 and Gab2 have opposing roles in the regulation of Akt
phosphorylation. Gab2 binds to the receptor complex more transiently, and its dissociation is hypothesized to be mediated by Shp2.
A detailed schematic using Systems Biology Graphical Notation (SBGN) [58] [59] is shown in Figure S1 in File S1. B, Along with the
signaling pathways, canonical pathways apply to all receptor complexes. All receptors or receptor complexes are internalized,
recycled and degraded at different rates for ligated and unligated receptors. These parameters are estimated based on optimization
of model outputs against experimental data. VEGF may dissociate from all VEGFR2 complexes, resulting in a disintegration of the
complex. ‘iR2’ and ‘dR2’ refers to internalized and degraded receptors respectively. ‘X’ refers to any molecular species bound to
VEGFR2.
doi: 10.1371/journal.pone.0067438.g001
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molecules from 0 to 120 minutes following addition of VEGF.
We assume that molecular species activated in response to
VEGF stimulation have initial steady-state concentrations at
zero time before the addition of VEGF. Parameter estimates
are obtained from previously published mathematical models
describing different receptor-ligand systems, namely VEGFR2
[32] and ErbB receptors [6–8]. The adaptor and scaffolding
proteins associated with ErbB receptors are similar to those of
VEGFRs as demonstrated through immunoprecipitation assays
[22,23] in HUVECs.
Molecular interactions
Biochemical reactions in this model can be broadly grouped
into six modules: (1) early receptor activation events such as
receptor-ligand binding and adaptor protein association; (2)
reactions describing Gab1 activation of the Akt pathway; (3)
proposed mechanisms for Gab2 antagonism; (4) Akt activation;
(5) receptor trafficking, including internalization, endosomal
sorting and degradation; and (6) VEGF dissociation from
VEGFR2 complexes.
Like the PDGF system, VEGF ligands are covalently pre-
dimerized. In our model, we assume that VEGFR2 are also
pre-dimerized. There are multiple possible mechanisms of
receptor dimerization [18], but that is not the focus in this study.
Ligand stimulation is approximated as a step-activation,
resulting in autophosphorylation of the VEGFR2 cytoplasmic
domains. This creates docking sites for SH2-domain containing
adaptor proteins Shc and Grb2. In our model, we do not
distinguish explicitly between receptor autophosphorylation at
the various tyrosine residues such as Y1175 and Y1214, as
there is limited relevant training data.
The phosphorylation of scaffolding proteins Gab1 and Gab2
is dependent on Grb2 [20]. Based on experimental studies in
VEGF-stimulated endothelial cells, the function of Gab1 is
similar to that of EGF-stimulated epithelial cells [22,23,33];
Gab1 mediates PI3K activation. Hence the reactions in module
2 – the Gab1-Akt module, reactions 5-8 and 14 of Table S1
and Figure S1 in File S1-are largely adapted from existing
mass action models of Gab1 activation in EGF systems [6,8].
Gab1 and Gab2 have similar binding domains, including
domains for Shp2 and PI3K. Hence, we hypothesize that both
Gab proteins associate with Shp2 and PI3K through similar
mechanisms. However, since Gab2 binds the receptor complex
more transiently than Gab1, we propose that its dissociation is
mediated by Shp2, for reasons described in the introduction
(Table S1 in File S1 reactions 9-13).
Akt is activated through the canonical PI3K/Akt pathway [7],
where the phosphorylation of PI3K by the receptor complex
catalyses the formation of PIP3 from PIP2. PIP3 production
may be reversed by phosphatase PTEN. Akt phosphorylation is
mediated by PDK1, whose association with PIP3 is necessary
for its catalytic function. Akt is dephosphorylated by
phosphatase PP2A. PP2A is activated through negative
feedback by doubly phosphorylated Akt represented by Aktpp.
These reactions are represented in Table S1 in File S1
reactions 15-30.
All receptor complexes are susceptible to receptor trafficking
processes. These are primarily modeled through three kinetic
parameters for each receptor complex, namely internalization,
recycling and degradation, with differential rates for ligated and
unligated receptors. Internalization and recycling are
represented as reversible first-order reactions (Table S1 in File
S1 reactions 31-44); degradation of the internalized molecules
is modeled as irreversible first-order reactions (Table S1 in File
S1 reactions 45-58).
Biochemical reactions in this model are written as first or
second order reactions. Cross-talk interactions between the
MAPK cascade and Akt cascade are not modeled here as Akt
signaling has been shown to be relatively independent of the
MAPK cascade [6] and hence was left out of a subsequent
study on therapeutically targeting PI3K/Akt signaling in ErbB
receptor systems [7].
Model parameters
Kinetic parameters associated with signaling molecules
common to RTKs (eg. Gab1, Shc, Akt etc) are taken from
previously published models [6–8,32]; this reduces the number
of parameters that must be estimated for these simulations
(Table S3 in File S1). These signaling molecules are likely to
be structurally similar regardless of ligand stimulation or
resident cell-type, and the kinetics of their reactions may be
conserved through different systems. On the other hand, the
kinetics of reactions that involve VEGFR2 are likely to be
receptor-specific, including ligand binding and receptor
trafficking. VEGF-VEGFR2 binding and dissociation rates are
derived from radioactive labeling experiments and Scatchard
plot analysis, and have been used in previously published
models [18]. VEGF receptor densities in primary endothelial
cells are approximately one order of magnitude less than ErbB
receptor densities in epithelial cell lines. In this model, the initial
VEGFR2 density is set using quantification experiments from
our group as a guide [34]. The average ligand concentration for
each cell is adjusted to a cell-volume basis, and estimated
using a 1 pL cell volume and 10mm cell culture medium depth.
Receptor trafficking parameters, which are likely to be receptor-
specific, were estimated as described in the next section.
Parameter fitting
Receptor trafficking kinetics including receptor
internalization, recycling and degradation were the only
parameters for which values were not available directly from
the literature or previous modeling efforts (Table S3 in File S1).
These kinetic parameters were estimated by optimization of the
model outputs against time-course phosphorylation profiles of
VEGFR2 [35,36] and Akt [37–39] on western blots. For
experimental studies where densitometric measurements are
available [36–38], the time-course profile can be read directly.
Where the western-blot images were published [35,39], we
measured the densitometry using the ImageJ Gel Analysis tool
[http://imagej.nih.gov/ij/]. Several experiments have also shown
VEGFR to have different endosomal sorting characteristics
from EGFR [40]. Since the experimental data provide relative
and not absolute concentrations, our fitting methodology
minimized least squares error between the normalized
simulation profiles and experimental datasets (Figure
S2B,D,F,H,J in File S1). The western-blot data available were
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semi-quantitative, and inherently relative to the control (no
VEGF stimulation) densitometry. The model, in contrast,
simulates absolute values of receptor densities and signaling
protein concentration profiles; therefore for the purpose of
comparison between the simulations and the experiments, we
assumed that the maximum concentration measured in
experimental data was a close approximation to the absolute
maximum value in the simulated concentration profile. This is a
fair assumption given that the experimental data points were
collected at sufficiently short time intervals.
The optimization routine was implemented using the trust-
region-reflective algorithm (lsqnonlin in MATLAB), and the
acceptable space for the six trafficking parameters was
constrained within physiologically relevant bounds (10-1 to 10-4
molecules/s). Each of the five relevant experimental datasets
(phosphorylation profiles of VEGFR2 [35,36] or Akt [37–39])
was used to create at least 30 distinct sets of fitted trafficking
parameters, starting from 50 runs of the simulations and
discarding those giving physically unfeasible results; this
resulted in 213 usable parameter sets in total. Each run used a
random initial value for each parameter (within the prescribed
bounds); the outcome of each run is a set of trafficking
parameters that best fit that dataset. Each run produces a
different set of trafficking parameters, and the resulting values
for each parameter were plotted, by experimental dataset
(Figure 2A–F) and with all experimental datasets aggregated
('All'). Note that since the number of parameters that can be
fitted was constrained by the number of datapoints, several
assumptions were made regarding the internalization, recycling
and degradation rates. It was assumed that unligated and
ligated receptor complexes have different internalization,
recycling and degradation rates. In particular, the faster
internalization rates of ligated receptors compared to unligated
receptors were observed in an in vitro system, in the context of
VEGF stimulation in bovine aortic endothelial cells (BAECs)
[41]. It was further assumed that all ligated receptor complexes
have the same internalization, recycling and degradation rates,
regardless of internal scaffolding and complexing.
As examples of the range of parameters that were found in
these best fits, two complete sets of trafficking parameters for
the Lamalice et al dataset [36] are indicated with orange and
blue stars (Figure 2A–F). Examining the range of values
obtained for each parameter set, we note that the range of
estimated values for each parameter is consistent between
experimental datasets (Figure 2A–F), and that the mean and
median values of these estimates is similar for each parameter
(Figure 2A–F, right). These results suggest that there is a high
likelihood that the true value of these parameters is within this
range. To maintain consistency throughout the rest of the
manuscript, and to validate these estimated values, one
parameter set out of the 213 fitted was chosen to be used as a
'base case' – specifically, the set labeled with orange stars in
Figure 2A–F, and listed at the end of Table S3 in File S1. The
parameter set was chosen because it had the lowest sum of
least squares error and the largest number of parameters fitted,
based on the availability of data for 8 time-points in the dataset
[36]. Note that the parameter set chosen is a single fitted set,
and thus not equivalent to choosing the median for each
parameter. Note also that these parameters are based only on
the Lamalice et al data set [36] and therefore the other four
datasets used in Figure 2A–F are independent of this and are
used for validation, along with two additional datasets that
provide measurements of signaling molecules intermediate
between VEGFR2 and Akt. This 'base case' set of parameters
is used to simulate VEGF stimulation experiments in vitro and
compared to published experimental results (Figure 2G–M).
Model Outputs
The model outputs are the concentrations of the various
signaling complexes (Figure S1 in File S1) over time. To match
these with experimental data, it becomes important to
aggregate some complexes together. For example, due to the
scaffolding and adaptor proteins, multiple molecular species in
the model contain phosphorylated VEGFR2. The sum of all
these is denoted ‘pR2’ (e.g. Figure 2G) and represents the
population of actively signaling receptor dimers. This includes
both membrane-associated receptors and internalized
receptors. As noted earlier, in this model, the internalized
receptors represent receptors in early endosomes while
degraded receptors represent those sorted into late
endosomes and marked for degradation; we assume that only
the receptors at the surface and in early endsomes are
signaling. A second example of aggregation is denoted ‘pAkt’
(e.g. Figure 2M), which is the sum of singly and doubly
phosphorylated Akt (Aktp + Aktpp) as both species are detected
in an immunoblot.
Sensitivity Analysis
To perform a sensitivity analysis of the model, we used the
eFAST method as described by Saltelli et al [42,43] and as
implemented by Kirschner and colleagues [44]. We used
Simlab 2.2 from Econometrics and Applied Statistics Unit
(EAS) at the Joint Research Centre (JRC) of the European
Commission (Ispra, VA, Italy; http://simlab.jrc.ec.europa.eu/).
The eFAST analysis method is described in more detail in the
Supplemental Methods in File S1.
Results
Model Parameterization and Validation
To understand the VEGF-induced impact of Gab1 and Gab2
on Akt phosphorylation, we developed a mass-action model
(described in Methods) to capture the signaling dynamics of
key molecular species in the network. Due to the VEGFR-
specific nature of the VEGFR trafficking parameters [40,45],
and to the high sensitivity of the model outputs to these
parameters (verified by analysis, see below), the trafficking
parameters (Table S1 in File S1 reactions 31-58 Table S3 in
File S1, parameters k_int, k_rec and k_deg) were optimized
against 5 time-course phosphorylation profiles of VEGFR2 or
Akt (Figure S2 in File S1), assayed in in vitro experiments of
VEGF-stimulated endothelial cells [35–39]. As described in
Methods, each experimental dataset provided multiple sets of
parameter measurements. For each parameter, these
estimates are consistent between each data set (Figure 2A–F),
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Figure 2.  Estimation of trafficking parameters and model validation using independent experimental data.  A–F, Six
VEGFR2 trafficking parameters were estimated by fitting simulation results to independent time-course western blots of protein
phosphorylation: Phosphorylated VEGFR2 data [35,36] and phosphorylated Akt data [37–39]. The number of fitted parameters for
each dataset is limited by the number of time-points at which the metrics were measured in that dataset. For each experimental
dataset, the fits were performed multiple times (Figure S2 in File S1) starting with different initial values for the parameters. The
outcome is a range of estimated values for each parameter (panels A-F). We show these parameter estimates in two ways: on the
left, all of the parameter estimates are shown in a dot plot, separated by experimental dataset, as well as aggregated ('All'); on the
right, the estimates are binned to show the high degree of clustering of parameter estimates (plus the mean and median values).
Two examples of complete parameter sets estimated by fitting to the same experimental dataset are indicated by the orange and
blue stars. The distribution of estimated values for each parameter is consistent between experimental datasets. The trafficking
parameters (rate constants) estimated using this method are: A, kintf, internalization of free receptors; B, kintb, internalization of
bound (VEGF-ligated) receptors; C, krecf, recycling of free receptors; D, krecb, recycling of bound receptors; E, kdegf, degradation
of free receptors; F, kdegb, degradation of bound receptors. G–M, Simulations recapitulate independent experimental observations
of VEGFR2 and Akt phosphorylation profiles and VEGFR2 recruitment of scaffolding proteins upon VEGF stimulation. Using one of
the parameter sets based on phosphorylated VEGFR2 time-course data from [36] (indicated with an orange star on panels A-F),
model simulation predictions for multiple molecular species are over-laid on independent experimental data from other published
sources. Western-blot time-course data were normalized to the maximum concentration computed by the model; no other fitting is
done. The molecules are: G, All membrane-associated and internalized phosphorylated VEGFR2 complexes [35]; H, All complexes
containing phosphorylated Gab1 (but not Shp2) [23]; I, All complexes in which Shp2 is bound to Gab1 [23]; J, All complexes in
which phosphorylated Shc is bound to Gab1 [23]; K, All molecular complexes containing phosphorylated Gab2 [22]; L, All species
where Shp2 is bound to Gab2 [22]; and M, Sum of singly and doubly phosphorylated Akt [37–39].
doi: 10.1371/journal.pone.0067438.g002
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acknowledging that we constrained the values to an overall
range of 3 orders of magnitude using the trust-region-reflective
algorithm. This suggests that the 'true' values of those
parameters are within these ranges. We selected a specific set
of parameter estimates using only the experimental data from
Lamalice et al of pVEGFR2 [36] – indicated by the orange stars
– as the baseline parameters for the remainder of this study.
To test the validity of this selected parameter set, we employed
the four remaining datasets used in Figure 2A–F (Chabot et al
for phosphorylated VEGFR2 [35]; Schneeweis et al, Bruns et al
and Zhang et al for phosphorylated Akt [37–39]), plus two
additional time-course experimental datasets of intermediate
signaling molecules (Laramee et al for Gab1 measurements
and Caron et al for Gab2 measurements [22,23]). In this way,
we validate the parameterized model by comparing the outputs
(concentrations of various signaling molecules, Figure 2G–M)
to a total of six independent published time-course datasets.
While we can estimate parameter sets from these other papers
(as shown in Figure 2A–F), we used them here as validation
only, validating parameters estimated using the Lamalice et al
pVEGFR2 data. The model reproduced the behavior of several
key nodes in the network from VEGFR2 to Akt, involving
scaffolding proteins Gab1, Gab2 and their respective
complexes with Shp2 (Figure 2G–M). As state variables in this
model are expressed as the difference from steady state, the
concentration profiles of key proteins demonstrate transient
signaling, where there is an increase in signal to a maximum,
followed by a return to basal levels of concentration. The
attenuation of phosphorylated receptor profiles at longer time
points is largely due to receptor internalization. Note, as
described in the methods, the aggregation of multiple
molecular species containing phosphorylated VEGFR2,
denoted 'pR2' (Figure 2G), and the aggregation of singly and
doubly phosphorylated Akt (Aktp + Aktpp), denoted 'pAkt' (Figure
2M). This aggregation allows us to compare the model output
with experimental results, in which the multiple phosphorylated
VEGFR forms are detected together and the multiple
phosphorylated Akt forms are detected together.
This model includes VEGF dissociation from VEGFR (Table
S1 in File S1 Reactions 59-70), a mechanism that is not always
included in RTK signaling models. Here, we assume the
disintegration of the entire VEGFR-complex upon the
dissociation of VEGF, which is an over-estimation for the effect
of VEGF dissociation. Yet, there is little change in the key
nodes of this network (Figure S3 in File S1) for typical VEGF
dissociation rates (kdV ~ 10-3/s) compared to no dissociation (kdV
= 0). While there is little change in the model outputs, the
inclusion of dissociation-disintegration reactions shifts the
sensitivity of many of the signaling complexes from being
primarily sensitive to internalization to a balance of
internalization and recycling rates (Figure S4 in File S1). This
suggests that the sensitivity to receptor recycling is
underestimated in models of RTK signaling that neglect the
dynamics of ligand dissociation.
We hypothesized that Shp2 associates quickly with R2p:
…:Gab2p complexes, i.e. complexes containing phosphorylated
VEGFR2, phosphorylated Gab2, and other elements in
between (Reaction 13, k_2dShp2) and mediates Gab2
dissociation from the VEGFR2 complex. This results in the
formation of the cytosolic complex Shp2: Gab2p:PI3K (Table S1
in File S1), which accounts for sustained signal in the co-
immunoprecipitation of Shp2-Gab2, as demonstrated
experimentally [22] (Figure 2L). The kinetic rate of Shp2
association with the VEGFR2 complex in this reaction
(Reaction 13, k_2dShp2) was set to be ten times that of the
typical Shp2 association with Gab proteins (Reactions 8 and
12). In this case, the total concentration of Gab2-bound
receptors (R2p:…:Gab2) reach a maximum of smaller
magnitude and more quickly than Gab1-bound receptors (R2p:
…:Gab1) (Figure 3A). The area under the curve (AUC) for R2p:
…:Gab2 is approximately 46% of that of R2p:…:Gab1. This
suggests a greater and more sustained response for Gab1 and
a corresponding increase in Akt phosphorylation downstream.
For other reactions that Gab1 and Gab2 have in common, such
as with PI3K and Shp2, the kinetic parameters for Gab1 and
Gab2 are the same. These concentration profiles are the sum
of internalized Gab protein-bound receptor complexes as well
as their membrane-bound counterparts (Figure 3B and 3C), as
would be detected in an experiment co-immunoprecipitating
VEGFR2 and Gab proteins. Note that a higher percentage of
measured Gab1 complexes would be active signaling
complexes than Gab2 complexes.
In VEGF-induced Gab protein activation, Shp2 recruitment is
predicted to dominate over recruitment of the p85 subunit of
PI3K in terms of magnitude (Figure S5 in File S1). In particular,
Shp2 recruitment by Gab1 peaks before PI3K (Figures S5A
and S5B in File S1). As is true for R2p:…:Gab1, R2p:…:Gab2
recruitment of Shp2 also dominates over the recruitment of
PI3K. A similar observation was made in experiments of Gab2
recruitment of p85 and Shp2 in EGF-induced MCF-10A cells
[30], where p85 recruitment was undetectable at an early stage
(2.5 min after ligand stimulation).
Inhibition of VEGFR2 degradation sustains Akt
phosphorylation
VEGFR2 degradation can be attributed in part to
proteasome-mediated proteolysis. To further validate model
outputs, we simulate the treatment of HUVECs with lactacystin,
which decreases the degradation rate of VEGFR2 (Figure 3D).
As demonstrated experimentally as well as in the simulations,
this results in a more sustained Akt phosphorylation (Figure
3F). In particular, these simulations suggest that a 67%
decrease in VEGFR2 degradation rates relative to the control
cells yields a pAkt profile (Figure 3E) closest to the
experimentally measured profile [37].
PI3K/Shp2 and Gab1/2 initial-concentration ratios
influence pAkt
PI3K and Shp2 are two main binding partners of the Gab
proteins. Relative concentrations between kinases and
phosphatases in a cell can be significant in influencing system
behavior. In this proposed mechanism, Gab1 and Gab2
compete for PI3K. Intuitively, the concentration of PI3K in the
endothelial cell is important in influencing the topology of this
network. The ratio of initial concentrations of PI3K and Shp2
needs to be less than one (i.e. PI3K < Shp2) for Gab2
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knockdown to have an appreciable negative effect on Akt
phosphorylation (Figure 3H). This was consistent over two
orders of magnitude of initial enzyme concentrations,
suggesting that within the range of physiologically relevant
concentrations of PI3K and Shp2, the ratio of kinase to
phosphatase is more important in influencing system behavior
Figure 3.  Simulations recapitulate differential Gab1/2 activation, in vitro experiments of lactacystin inhibiting proteasome-
mediated proteolysis and knockdown of Gab1/2 using siRNA.  A–C, VEGFR2 recruitment of Gab1 is greater, slower and more
sustained than that of Gab2. B and C, Molecular species that make up concentration profiles in (A), at early time points.
‘Internalized’ refers to the receptor complexes in the endosomal pool and ‘Surface’ refers to plasma-membrane-associated receptor
complexes on the cell surface. Model base case values are available in supplement File S1 (Tables S2 and S3 in File S1). D,
Decreasing VEGFR2-complex degradation rates result in pR2 profiles that are larger in magnitude and more sustained. E,
Experimental time course data of pAkt (i.e., Aktp + Aktpp) from [37] over-laid with model simulations of decreasing VEGFR2-complex
degradation rates. SSE: Sum of Squared Error, kdegb: degradation rate of VEGF-bound VEGFR2-complexes. F, Half-maximum
duration of pAkt decreases with increasing degradation rates. G, Change in Akt phosphorylation in response to Gab knockdown
("KD") where PI3K/Shp2 is 0.1 and Shp2 initial concentration is at 106 molecules/cell. H, PI3K/Shp2 ratio tunes effect of Gab
knockdown on Akt phosphorylation.
doi: 10.1371/journal.pone.0067438.g003
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than the absolute concentrations. At higher concentration ratios
of PI3K/Shp2 in the cell, the lipid kinase is not limiting and Akt
is phosphorylated to the same extent regardless of Gab2
knockdown. This implies that sufficient PI3K is activated for
maximal Akt phosphorylation.
To study the effect of siRNA knockdown experiments in vitro,
we simulated a range of decreases in Gab protein initial
concentrations. As demonstrated in [22], an experimental
knockdown of Gab1 decreased pAkt by 32% at 10 minutes and
24% at 20 minutes. Here, our model predicts that for a 90% KD
of Gab1, maximum pAkt decreases by 73.5%. Similarly, in the
experimental knockdown of Gab2, pAkt increases 46% at 10
min and 66% at 20 mins relative to the corresponding time
points in the control experiment. Here, the model predicts a
maximum 39.6% increase in pAkt compared to the control.
These figures serve to demonstrate that the model
recapitulates semi-quantitative experimental data within
reasonable variability. We also studied the input-output
characteristics between Gab protein concentration and Akt
phosphorylation. Following Gab1 knockdown in our model, a
log-linear relationship was predicted between a decrease in Akt
phosphorylation and decrease in Gab1 concentration, but a
linear relationship between a Gab2 knockdown and an
increase in Akt phosphorylation (Figure 3G).
The initial concentration of Shp2 is also important in the
proposed mechanism. Decreasing the initial concentration of
Shp2 increases the total proportion of free Shp2 consumed in
the various biochemical reactions (Figure 4A–C). This seems
counter-intuitive, since the presence of more reactants should
yield more products. However, in this network, there are 3
reactions that involve free Shp2 (Reactions 8, 12, 13 of Table
S1 in File S1). The dominance of each reaction is dependent
on the initial concentration of Shp2. In a high-Shp2 regime, the
formation of R2p: Shcp: Grb2: Gab2p: Shp2 is proportionally
large (Figure 4A, brown, yellow and blue). On the other hand,
in a low-Shp2 regime, the formation of Shp2: Gab2p:PI3Kp is
proportionally large (Figure 4C, cyan). This indicates that in the
low Shp2 regime, the pathway through R2p: Shcp: Grb2:
Gab2p:PI3Kp dominates, and leads to the feedback reaction,
which recycles R2p: Shcp: Grb2 and forms Shp2: Gab2p:PI3Kp
(Figure 1). This recycling effect results in the presence of more
active receptor complexes, which can go down multiple
possible pathways and one possibility is the production of more
Shp2-containing complexes. Although reactions involving Shp2
and Gab2 generally repress Akt activation, the model predicts
that the transient binding of Gab2 and hence the recycling of
R2p: Shcp: Grb2 can, depending on the mass fluxes at
particular instants in time through the simulation, partially
promote Akt activation.
In general, the dependence of molecular complexes on Shp2
initial concentration generally reflects whether or not that
particular molecular complex promotes active Akt
phosphorylation. Molecular complexes that are Akt-activating
have a negative slope (Figure 4G–I), in other words, they
decrease with increasing Shp2 concentration. In contrast, Akt-
deactivating species have a positive slope (Figure 4D-E),
increasing with increasing Shp2 concentration, with the
exception of Shp2: Gab2p:PI3Kp. While Shp2: Gab2p:PI3Kp
sequesters PI3K in the cytosol, hence reducing Akt activation,
the plot for Shp2: Gab2p:PI3Kp shows a negative slope (Figure
4F), which is typical of an Akt-activating signaling molecule.
The recycling of R2p: Shcp: Grb2 is coupled with the formation
of Shp2: Gab2p:PI3Kp and this reaction is partly Akt-activating.
Given that Gab1 and Gab2 have opposite roles upon VEGF
stimulation in HMVECs, it is intuitive to ask: what is the
threshold ratio of Gab1: Gab2 protein initial concentrations that
would render one completely dominant over the other? Local
sensitivity of Gab1 or Gab2 initial concentration with respect to
Aktpp suggests that a ratio of ten-fold would render one Gab
protein substantially dominant over the other (Figure 4J–L).
The basal level of each Gab protein is 105/cell in this model.
Interestingly, given different kinetics between Gab1 and Gab2
association with the receptor complex, their initial concentration
ratio influences Akt phosphorylation through several orders of
magnitude of Gab protein concentration, and the ratio of
concentrations is more determinative than the absolute
concentration of either molecule (Figure 4L).
System is more sensitive to VEGF concentration than
VEGFR2 density at a single cell level
Changes to the exogenous VEGF concentration affects the
magnitude and time-to-peak of receptor phosphorylation
profiles (Figure 5A–F), while altered VEGFR2 density only
affects its magnitude (Figure 5G–I; note the different y-axis
scales). Specifically, decreasing VEGF concentration
decreases the magnitude of the receptor phosphorylation
profile and delays its time-to-peak. Furthermore, decreasing
VEGF concentration increases the proportion of larger receptor
complexes internalized, such as R2p: Shcp: Grb2:
Gab1p:PI3Kp:PIP2 (Figure 5D–F). This occurs because ligated
receptors are internalized and recycled faster than unligated
receptors. Hence, with lower ligand concentrations, net
receptor internalization rates are lower, and larger membrane-
associated receptor complexes can form before internalization
occurs. VEGF ligand availability is dynamic due to receptor
trafficking. This may account for the variability in time-to-peak
in VEGFR2 phosphorylation profiles as measured in published
cell culture experiments, despite similar VEGF concentrations
being used.
Recent studies in VEGFR trafficking have demonstrated that
it is not simply a mechanism for signal downregulation, which
had been the conventional assumption. Rather, it facilitates
different signaling mechanisms that have significant impacts on
cell physiology [46,47]. Hence the distribution (cell surface/
intracellular) of receptors in the endothelial cell may be an
important metric, indicative of the extent of activation of the
various downstream pathways. In our simulations, the ratio of
the concentrations of cell-surface receptors and internalized
receptors were consistent at all ligand concentrations. Over
100 minutes after addition of VEGF, the time-integrated
concentration of cell-surface receptors was calculated to be
~86% of the total receptor population. Experimental studies
also show that internalized pool of VEGFR2 is not negligible,
both in quiescent [45] and stimulated [40] states. Since
receptor trafficking is dynamic and ligand-dependent, variability
is expected.
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Figure 4.  Akt phosphorylation is sensitive to the initial concentrations of Shp2 and Gab1/2.  A–I, Decreasing the initial
concentration of Shp2 increases the total proportion of free Shp2 consumed. Different biochemical reactions dominate with changes
in initial Shp2 concentration. A, Shp2 Initial Concentration at 107 molecules/cell; B, at 106 molecules/cell; C, at 105 molecules/cell.
‘Deg’ refers to receptor complexes sorted into late endosomes and eventually degraded. ‘Int.’ refers to internal, includes the
receptor complexes in the endosomal pool and cytosol. ‘Surf.’ refers to plasma-membrane-associated receptor complexes on the
cell surface. D–I, Sensitivity to initial Shp2 concentration of Akt-activating species (D–F) and Akt-nonactivating species (G–I).
Positive slopes indicate an increase in concentration of that molecule with increasing Shp2. Concentrations are in units of
molecules/cell. J–L, The ratio of concentrations of Gab1 to Gab2 influences Akt phosphorylation. J and K, The dependence of the
concentration of doubly phosphorylated Akt on the initial concentrations of (J) Gab1 and (K) Gab2 initial concentrations in various
time points. L, Predicted maximum Akt phosphorylation, relative to the baseline simulation ([Gab1] = [Gab2] = 105/cell). Akt
phosphorylation increases with increasing value of the ratio of Gab1/Gab2 initial concentration. The ratio appears to be more
important than the individual values of Gab1 and Gab2, as shown by changing the ratio by varying Gab1 concentration (blue line,
constant Gab2) and by varying Gab2 concentration (green line, constant Gab1).
doi: 10.1371/journal.pone.0067438.g004
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Decreasing receptor density is predicted to impact only the
magnitude of receptor phosphorylation profiles but not the
timing (Figure 5G–I, note the different y-axis scales); the
phosphorylated VEGFR2 profile scales linearly with initial
VEGFR2 density. The proportion of the various receptor
complexes also remains largely constant regardless of receptor
Figure 5.  Effect of receptor-ligand kinetics on Akt phosphorylation.  A–F, Receptor phosphorylation dynamics in response to
VEGF concentrations: (A,D) 500 ng/ml; (B,E) 50 ng/ml; and (C,F) 5ng/ml. R2p refers to plasma membrane-associated receptors,
iR2p refers to internalized receptors. Estimates of VEGF concentration based on a 1 picoliter cell volume. G–I, Receptor
phosphorylation dynamics in response to different VEGFR2 densities: G, 1000 VEGFR2-dimers/cell; H, 5,000 VEGFR2-dimers/cell;
and I, 10,000 VEGFR2-dimers/cell. J and K, Sum of singly and doubly phosphorylated Akt corresponding to simulations in panels A-
F (J) and panels G-I (K). R2 here refers to dimerized VEGFR2 receptors. ‘Int.’ refers to the receptor complexes in the endosomal
pool and ‘Surf.’ refers to plasma-membrane-associated receptor complexes on the cell surface.
doi: 10.1371/journal.pone.0067438.g005
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density. This may be because model presented here is a
single-receptor-type, single-cell model; at the tissue level [48],
in the presence of multiple receptor types and co-receptors
(neuropilins), the sensitivity of receptor densities will differ.
Interestingly, Akt phosphorylation profiles remain largely
robust to order-of-magnitude changes in receptor density and
ligand concentration (Figure 5J-K). In in vitro experiments,
50-100ng/ml are the highest concentrations of VEGF used;
5-20 ng/ml are typical. Here, the simulations indicate that there
are saturation thresholds of ligand concentration and receptor
density for maximal Akt activation.
Modular Sensitivity Analysis
Parameters in this system were organized into several
modules and Extended Fourier Amplitude Sensitivity Test
(eFAST) analysis [42,43] was performed to quantify
interactions between parameters in each module.
Phosphorylation-dephosphorylation signal transduction
systems such as these are often characterized as insulators,
due to the fast time-scales of these reactions relative to the
decay of the inputs [49]. Insulated modules act relatively
independently of upstream inputs and downstream outputs.
eFAST analysis was performed for the some of the most
sensitive parameters from each module to quantify interactions
between modules, if any. The Total FAST Index of an input is
the normalized sum of its variance and covariances with other
inputs, in all possible combinations, with respect to an output
(see Supplemental Methods in File S1). As such, it is not
possible to show which specific higher order interactions
dominate for each input parameter. Given this non-identifiable
nature of the eFAST Total Indices and the complexity of this
model, limiting the number of parameters in each eFAST
analysis avoids the computation of spurious interactions
between parameters in the system. Specifically, the sets of
parameters investigated were as follows: initial concentrations
of unique proteins in the system (Figure S6 in File S1); kinetic
parameters in reactions involving Gab1 (Figure 6A); kinetic
parameters in reactions involving Gab2 (Figure 6B); VEGFR2
trafficking kinetics (Supplemental Figure S4 in File S1); and
finally, a combination of more sensitive parameters from the
aforementioned analyses (Figure 6C). Sensitivity indices were
computed for all the receptor complexes (plasma membrane-
associated and internalized) and for Akt (singly and doubly
phosphorylated). Sensitivity indices of internalized receptor
complexes are not presented here because they were identical
to their membrane-associated counterparts, as expected.
A 'dummy' parameter, i.e. one that does not appear in the
model, is introduced in the eFAST analysis to quantify the
extent of aliasing in the analysis [44] (Figure 6). Dummy
parameters can have non-negligible FAST indices when none
of the input parameters are important to a particular output; for
example, kinetic parameters in the Gab1 and Gab2 modules
(e, g, kaGab1, kaGab2) have little effect on the formation of
small VEGR2 complexes such as R2p: Shc and R2p: Shcp
(Figure 6C). When the FAST indices are normalized, the
parameters (including the dummy) tend to have large but fairly
equal FAST indices throughout, indicating a small signal to
noise ratio.
The sensitivity of signaling molecules to initial concentration
parameters is important, because protein concentrations often
depend on cell types and culture conditions. Using the eFAST
analysis, receptor density appears to be the most significant of
all initial-concentration parameters (Figure S6 in File S1).
Based on the stoichiometry in the model, VEGFR2 is limiting
and changes to receptor density scales the receptor
phosphorylation profile linearly (Figure 5G–I). VEGF
concentration affects the duration of the signal to a greater
extent, which is not captured in this analysis based on time-
integrated data. Receptor density and initial ligand
concentrations have a large impact on small receptor
complexes (R2p: Shc, R2p: Shcp), but VEGFR2 complexes
bound to more than one adaptor molecule (Shc) are predicted
to be almost completely insulated from the changes in VEGF
concentration across 2 orders of magnitude. This verifies the
simulations that demonstrate a robust Akt phosphorylation
response, regardless of changes in the receptor
phosphorylation profile (Figure 5). Interestingly, the R2p:
…:Gab1 complex is more sensitive to initial concentrations of
Shp2 and PI3K than to Gab1; but initial concentrations of both
Gab1 and Gab2 are important (along with PI3K and Shp2) in
influencing R2p:…:Gab2. In fact, Gab1 initial concentrations
appears to influence the formation of R2p:…:Gab2, more than it
does R2p:…:Gab1. These results indicate asymmetry between
the Gab1 and Gab2 modules, although many of their binding
partners, reactions and reaction rates are similar.
Similarly, the Gab1 and Gab2 modules are differently
sensitive to their kinetic parameters (Figure 6A-B), another
indication that the system is not symmetric. For example, of the
Gab-module kinetic parameters, R2p:…:Gab2 is most sensitive
to kaGab2 (Figure 6B, dark blue), while R2p:…:Gab1 is least
sensitive to kaGab1 (Figure 6A, dark blue). Conversely, R2p:
…:Gab1 is most sensitive to k1PI3K (Figure 6A, green) but R2p:
…:Gab2 is least sensitive to k2PI3K (Figure 6B, cyan), with the
exception of R2p: Shcp: Grb2: Gab2p:PI3Kp. Parameters in
reactions involving Gab1 generally have a smaller and non-
synergistic effect on molecular species involving Gab2 (Figure
6A, bottom four rows). The same is observed for parameters in
reactions involving Gab2 and Gab1-parameters. The quick
phosphorylation rates of Gab1 and Gab2 (kpGab1, kpGab2)
may contribute to the insulation between Gab1 and Gab2
modules.
The ranking of Gab2-module parameters to which each R2p:
…:Gab2 complex is sensitive is different (Figure 6B). In
comparison, more similarities in ranking are observed in the
Gab1 module. Interestingly, receptor complex formation is least
sensitive to the parameters governing the dissociation of Gab2
from the receptor complex (k2dShp2 and kd 2dShp2) (Figure
6B), suggesting that the proposed dissociation reaction
mediated by Shp2 (Reaction 13) recapitulates experimental
data but has a small effect on the overall system behavior. This
is encouraging, since these parameters have no precedent
estimates in the literature.
The kinetic parameter for the dissociation of Gab2 from the
receptor complex (k2dShp2) is one to which all molecular
species except R2p: Shcp: Grb2: Gab2p:PI3K appear to be
insensitive; both the first-order and total eFAST indices for
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k2dShp2 and R2p: Shcp: Grb2: Gab2p:PI3K are high, and the
difference between the Total and First indices for this input-
output pair is largest amongst all other pairs in this analysis.
This means that k2dShp2 interacts with other parameters in
Gab2-module reactions to exert an impact on R2p: Shcp: Grb2:
Gab2p:PI3K (Figure 6B).
Finally, to understand which parameters the signaling
complexes are most sensitive to, we conducted an eFAST
analysis on a selection of those parameters to which the
signaling complexes were shown to be most sensitive in each
of their respective modular eFAST analyses. The selected
parameters include initial concentrations, kinetic parameters in
the Gab1 and Gab2 modules, as well as the VEGFR2
trafficking module. The signaling complexes are most sensitive
to the trafficking parameters involving the internalization,
recycling and degradation of pR2 (Figure 6C). This result
demonstrates the necessity in fitting the trafficking parameters
against experimental data.
Model outputs show that the rate of dissociation of Gab2
from the receptor complex (k2dShp2) affects the distribution
Figure 6.  eFAST First and Total sensitivity Indices for select parameters and molecular species.  Internalized counterparts of
receptor complexes not presented here have identical sensitivity indices as their membrane-associated counterparts. A, R2p :
…:Gab1 and R2p:…:Gab2 sensitivity to kinetic parameters in the Gab1 module. B, R2p :…:Gab1 and R2p:…:Gab2 sensitivity to
kinetic parameters in the Gab2 module. C, eFAST analysis on the initial-concentration and kinetic parameters shown to be most
sensitive on each of their respective modular eFAST analyses.
doi: 10.1371/journal.pone.0067438.g006
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between Gab1- and Gab2-associated VEGFR receptors
(Figure 7). However, above a threshold of about 10-4/
molecules/s, a faster dissociation rate ceases to have an effect
on the system. Figure 7 demonstrates that this holds through
time and that the parameter does not result in a marked delay
in time-to-peak. Molecular complexes that form as a result of
Gab1 association with the receptor (Figure 7A–C), regardless
of whether it is signal-downregulating (Figure 7A) or signal-
activating (Figure 7B), increase with increasing dissociation
rate (k2dShp2). It follows that with increased formation of R2p:
Shcp: Grb2: Gab1p:PI3Kp:PIP2 at faster k2dShp2 rates, Akt
phosphorylation follows the same trend, being downstream of
the former. Increasing dissociation rates of Gab2 from the
receptor (kd aGab2) decreases the proportion of Gab2-bound
receptors (Figure 7D), while increasing the formation of the
inactive cytosolic complex Shp2: Gab2p : PI3Kp, byproduct of
the dissociation reaction.
Discussion
We described here the first deterministic mass-action model
that describes and predicts part of the VEGFR2 signaling
network in a comprehensive fashion. It is also the first to
describe both Gab1 and Gab2 in modulating downstream
signaling. One of the challenges of developing models of signal
transduction is defining its scope: the level of detail necessary
to recapitulate experimental evidence, yet tractable in
complexity. The use of fundamental first- and second-order
kinetic equations here rather than Michaelis-Menten or Hill
approximations allow the study of signaling input-output
characteristics of modules in this network. Importantly, it
provides more flexibility in the demarcation of these modules,
and facilitates the understanding of specific reactions in the
context of others. This model focuses on the opposite roles of
scaffolding proteins Gab1 and Gab2. While ubiquitous in
intracellular systems, scaffolding proteins exhibit different
behavior in regulation of major signaling pathways, specific to
the receptor-ligand pair. A more mechanistic understanding of
the VEGFR2 signaling pathways in the context of these
scaffolding proteins is crucial in devising both anti- and pro-
angiogenic therapies for cancer and ischemia respectively.
In this study, we show that differences in kinetics of Gab1
and Gab2 scaffolding proteins affect Akt phosphorylation to
different extents. VEGFR2 recruitment of Gab1 is greater in
magnitude, slower, and more sustained than that of Gab2. As
Gab2 transiently binds VEGFR2 complexes, there is a
recycling of VEGFR2 complexes, which can then continue to
participate in other signaling pathways, possibly Akt-activating
or -deactivating. Correspondingly, a log-linear relationship was
observed between a decrease in Akt phosphorylation and
Gab1 knockdown while a linear relationship was observed
between an increase in Akt phosphorylation and Gab2
knockdown. Another theme in this study is the significance of
initial-concentration ratios of antagonistic molecular species
Gab1/Gab2 (Figure 4L) in determining Akt phosphorylation
profiles regardless of each protein’s concentration, within
physiologically relevant ranges. However, when two
antagonistic pairs, Gab1/Gab2 and PI3K/Shp2, were studied
simultaneously (Figure 3H), their effect on pAkt profiles was
less predictable.
The objective for developing such a computational model is
not to predict concentration profiles or estimate parameters
with good accuracy but rather, to predict, in a semi-quantitative
fashion, a system-wide response to cellular interventions of
Figure 7.  Sensitivity of model outputs to Gab2 dissociation rate from VEGFR2 complex.  A–B, Sensitivity of Gab1-associated
VEGFR2 complexes, C, Sensitivity of singly phosphorylated Akt, D-E, Molecular species in the Gab2 module. D, Sensitivity of R2p:
Shcp: Grb2: Gab2p: Shp2, an inactive Gab2-associated VEGFR2 complex and E, Sensitivity of cytosolic complex Shp2:
Gab2p :PI3Kp.
doi: 10.1371/journal.pone.0067438.g007
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biological interest. These may include the therapeutic
administration of molecular drugs such as tyrosine kinase
inhibitors (TKIs), overexpression of key signaling proteins or
knockdown experiments. Although this model was trained with
semi-quantitative data from five published experimental
datasets in different in vitro set-ups, we have observed order-
of-magnitude-consistent optimization estimates within the
physiologically relevant range for these parameters, spanning
three orders of magnitude. This suggests that the parameters
can reasonably be expected to reside within this narrower
range of values (Figure 2A–F). Furthermore, this model
recapitulates experimental data describing profiles of
scaffolding protein interactions in response to VEGF
stimulation [22,23], as well as interventions involving inhibition
of proteasome-mediated proteolysis of VEGFR2 and Gab1/
Gab2 siRNA experiments [22]. It has been shown that poorly
constrained parameters are inherent to large nonlinear ODE
models unless highly accurate and complete datasets are
available [50]. Such datasets are difficult to obtain with the
current state-of-the-art technology. Nonetheless, this model
may be used to identify parameters to which the key
signaling molecular complexes are sensitive, warranting further
experimental investigation. The topology of this model is also
congruous with several experimental observations both in in
vitro VEGF systems as well as other RTK systems
[7,11,15,51,52].
In this model, eFAST was used as the primary tool for
sensitivity analysis, which allows for the assessment of
parameter sensitivity over a larger and statistically defined
parameter space. Total FAST indices compare the sum of
variances of each input and covariances between each input
and all combinations of other inputs, with variance of each
output. Hence, parameters with much larger total FAST indices
compared with first FAST indices indicate that the parameter is
important in concert with other parameters but less so on its
own. Notably, one such parameter (k2dShp2) in this model
accounted for the dissociation of Gab2 from the VEGFR2
complex, suggesting that the parameter should be studied in
tandem with the rest of the parameters in the Gab2 module. In
addition, we have shown that internalization and degradation
kinetics of VEGFR2 are particularly sensitive and impact
downstream Akt phosphorylation.
This model describes a competition between Gab1 and
Gab2, for PI3K and hence the control of Akt activation.
Arguably, competition between Gab1 and Gab2 can also occur
at the level of PIP3 and Akt. The pleckstrin homology (PH)
domain is well conserved between Gab family proteins and
binds PIPs. PIPs account for membrane recruitment of Gab
proteins. Lacking an intrinsic catalytic unit, PIP3 is a less active
node in the pathway than PI3K. Competition between Gab1
and Gab2 for Akt is less likely as there is limited evidence of
Akt-Gab protein binding. Akt-Gab2 association has been
reported once [26] and Akt-Gab1 association has not been
observed [20]. Another limitation in this model is the inclusion
of VEGFR2 homodimers as the only VEGFR type. VEGFR1 is
less well understood than VEGFR2; it has a lower kinase
activity than VEGFR2, but does have a role in regulating
VEGF-stimulated signaling [39].
Validation of computational models relies on experimental
data; detailed quantitative experimental methods are relevant
to the future development of this and related models. For
example, the ubiquity of phosphorylation in signaling dynamics
may require more high-throughput experimental studies for an
unbiased understanding. Recently, mass spectrometry has
been used to study time-dependent phosphoproteomics in the
EGFR [53], HER2 [54] and IGFR signaling networks [55]. While
conventional western blots are reliable and relatively accurate,
their measurement is hypothesis-driven, and the likelihood of
finding novel signaling proteins and pathway crosstalks is
smaller. Nevertheless, western blots are still invaluable in the
verification of results from mass spectrometry. The use of less
specific phosphotyrosine antibodies is necessary for such
global experimental studies. As a result, there is lower
accuracy and the need for additional validation. The
identification of new biomarkers strongly correlated with cellular
processes such as migration and proliferation [54] can be
useful in the construction of models predictive of such
processes important to angiogenesis. In addition, this
technology can be extended to study patient-specific drug
response from a phosphoproteomic perspective [55].
Given the setup of this model, it is possible to extend it to
describe in greater detail VEGFR trafficking mechanisms and
their signaling consequences, as well as other canonical
pathways such as MAPK cascade and PLCϒ/PKC and their
crosstalk mechanisms. With recent experimental evidence,
trafficking mechanisms have been shown to be distinct from
other RTKs [40,45,56] and significant in endothelial cell
physiology [46,47]. The paradigm of receptor trafficking as an
indispensable signaling mechanism adds a new layer of
complexity that renders these systems less predictable. For
example, Protein Tyrosine Phosphatase-1B (PTP-1B),
localized on the endoplasmic reticulum, has anti- and pro-
signaling roles in RTK signaling; anti-signaling in the
dephosphorylation of RTKs, and pro-signaling in the
downregulation of multivesicular body (MVB) formation in late
endosomal sorting [57]. Systems biology is necessary in
describing this dynamic interplay between trafficking and
signaling mechanisms, pro- and anti-signaling components,
kinases and phosphatases, altogether.
This model is the first to simulate VEGF receptor-specific
intracellular signaling. The model can recapitulate certain key
aspects of VEGF receptor signaling that are distinct from other
receptor tyrosine kinases, notably the behavior of Gab1 and
Gab2 in influencing Akt activation. This is important, because
targeting VEGF pathways in disease requires a specific
understanding, rather than therapies generically targeting
proteins that are downstream of many receptors. In addition, a
key observation of the models is that certain concentration
ratios are more important than individual concentrations in the
behavior of the intracellular signaling system. This has
implications for personalized medicine, for example, in which
biomarkers may constitute more than one protein or gene. The
model developed here also includes VEGFR trafficking
mechanisms and therefore can be expanded to study multiple
signaling contexts (e.g. cell surface vs. intracellular signal
initiation) as well as receptor crosstalk. The model can also
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form a basis for investigation of therapeutic approaches, such
as tyrosine kinase inhibitors, overexpression of key signaling
proteins or knockdown therapies.
Supporting Information
File S1.  Supporting information for this study.  This file
contains Table S1-S3, which list the reactions and parameters
used in the computational model. It also contains Figure S1-S6,
which contain a detailed schematics, as well as additional
results figures. Finally, it includes one section of supplemental
methods, describing the sensitivity analysis for this study.
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